Search Results
Journal Article
Biotech by any other measure
Without a standard way to measure biotech, some other indicators are worth a look
Working Paper
State Incentives for Innovation, Star Scientists and Jobs: Evidence from Biotech
We evaluate the effects of state-provided financial incentives for biotech companies, which are part of a growing trend of placed-based policies designed to spur innovation clusters. We estimate that the adoption of subsidies for biotech employers by a state raises the number of star biotech scientists in that state by about 15 percent over a three year period. A 10% decline in the user cost of capital induced by an increase in R&D tax incentives raises the number of stars by 22%. Most of the gains are due to the relocation of star scientist to adopting states, with limited effect on the ...
Journal Article
An overview of science and cents: exploring the economics of biotechnology
This article provides an overview of the conference "Science and Cents: Exploring the Economics of Biotechnology," hosted by the Federal Reserve Bank of Dallas in April 2002. The conference brought together distinguished experts who spoke about economic and scientific issues surrounding biotechnology. In this article, John Duca and Mine Ycel summarize the presentations made at the conference. Topics covered include funding, location, and legal issues confronting the biotech industry. The interdisciplinary nature of biotech research, along with recent advances and future applications, is ...
Journal Article
Biotech and the San Antonio economy
Journal Article
Biotech bonanza: prospects for Texas
Journal Article
Taking the pulse of biotech: a conversation with Nancy Chang
Journal Article
Seeds of change
It's been eight years since genetically modified seeds first came on the market. Farmers have seen some advantages, but certain consumers, particularly those abroad, are still resisting the technology.
Journal Article
From laboratory to market: the biotechnology industry in the Third District
In "From Laboratory to Market: The Biotechnology Industry in the Third District," Tim Schiller describes major biotechnology products and reviews estimates of the industry's size and scope. He also outlines where the industry is most active in the United States, especially in the Third District states of Pennsylvania, New Jersey, and Delaware.
Journal Article
New England's take on biotech
Journal Article
Agricultural biotechnology: dividends and drawbacks